EUVIMEDOpdag EUVIMED
Crossref

Biomarkers to predict 30‐day mortality in patients with Fournier's gangrene disease: a retrospective study

Akile Zengin iD, Gokberk Alagas, Yusuf Murat Bag iD, Ahmet Murat Sendil iD, Ahmet Umit Cebeci, Elif Gundogdu iD, Yavuz Selim Angin iD, Mehmet Kılıc iD, Murat Ulas iD

ANZ Journal of Surgery · 2025

DOI: 10.1111/ans.70025 ↗

At a glance

Journal article in ANZ Journal of Surgery, 2025. Written by Akile Zengin and 8 co-authors. Institution: Department of Gastrointestinal Surgery, Eskisehir Osmangazi University, Eskisehir, Turkey. Major MEDLINE topics: Fournier Gangrene, C-Reactive Protein. Cited 1 times so far (Crossref); 23 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aim

Fournier gangrene disease (FGD) is a condition that requires emergent surgery due to its high risk of mortality. The use of biomarkers to predict outcomes after surgery for patients with FGD may be critical, as they assist in tailoring treatment approaches to individual needs. Our aim in our study is to investigate the presence of simple and easily accessible biochemical markers that can be used to predict early mortality.

Methods

The medical records of 100 patients diagnosed with FGD at our hospital between January 2015 and December 2023 were retrospectively reviewed. Clinical and laboratory variables were assessed, and predictive factors for mortality were analyzed using multivariate logistic regression.

Results

Demographics and perioperative clinical data of the whole study group, and subgroups according to the mortality status are evaluated. CRP was found to be independent predictor for 30‐day mortality in FGD. In ROC curve analysis provided a cutoff value of 121.3 mg/L for CRP which was significantly associated with 30‐day mortality for FGD.

Conclusion

Preoperative CRP ≥ 121.3 mg/L value could be predict 30‐day mortality in patients diagnosed with FGD.

Subjects

MeSH terms (MEDLINE)

Fournier GangreneC-Reactive ProteinHumansRetrospective StudiesMaleBiomarkersMiddle AgedFemaleAgedAdultPredictive Value of TestsROC CurvePrognosis

Author keywords

CALLYC‐reactive proteinFournier's gangrenemortalitynecrotizing fasciitisprediction

Substances

BiomarkersC-Reactive Protein

Authors and institutions

  • Department of Gastrointestinal Surgery, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Department of General Surgery, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Department of General Surgery, Ankara Training and Research Hospital, Ankara, Turkey.
  • Department of Radiology, Eskisehir Osmangazi University, Eskisehir, Turkey.

ORCID profiles: Akile Zengin, Yusuf Murat Bag, Ahmet Murat Sendil, Elif Gundogdu, Yavuz Selim Angin, Mehmet Kılıc, Murat Ulas

Cite

APA

Zengin, A., Alagas, G., Bag, Y. M., Sendil, A. M., Cebeci, A. U., Gundogdu, E., Angin, Y. S., Kılıc, M., & Ulas, M. (2025). Biomarkers to predict 30‐day mortality in patients with Fournier's gangrene disease: a retrospective study. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70025

Vancouver

Zengin A, Alagas G, Bag YM, Sendil AM, Cebeci AU, Gundogdu E, et al. Biomarkers to predict 30‐day mortality in patients with Fournier's gangrene disease: a retrospective study. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70025

BibTeX
@article{Zengin2025,
  author = {Zengin, Akile and Alagas, Gokberk and Bag, Yusuf Murat and Sendil, Ahmet Murat and Cebeci, Ahmet Umit and Gundogdu, Elif and Angin, Yavuz Selim and Kılıc, Mehmet and Ulas, Murat},
  title = {Biomarkers to predict 30‐day mortality in patients with Fournier's gangrene disease: a retrospective study},
  journal = {ANZ Journal of Surgery},
  year = {2025},
  doi = {10.1111/ans.70025}
}
Start for free →